Open Access
Issue
J Extra Corpor Technol
Volume 56, Number 2, June 2024
Page(s) 45 - 54
DOI https://doi.org/10.1051/ject/2024004
Published online 18 June 2024
  1. Quaniers JM, Leruth J, Albert A, Limet RR, Defraigne J-O. Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. Ann Thorac Surg 2006;81(5):1683–1690. [CrossRef] [PubMed] [Google Scholar]
  2. Melek FE, Baroncini LAV, Repka JCD, Nascimento CS, PrécomaPrécoma DB. Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation. Rev Bras Cir Cardiovas 2012;27(1):61–65. [CrossRef] [Google Scholar]
  3. Clive Landis R, Murkin JM, Stump DA, et al. Consensus statement: Minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum 2010;13:E116–E123. [Google Scholar]
  4. Rubens FD, Nathan H, Labow R, et al. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 2005;79(2):655–665. [CrossRef] [PubMed] [Google Scholar]
  5. He Z, Lu H, Jian X, et al. The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass. Blood Purif 2022;51(1):31–37. [CrossRef] [PubMed] [Google Scholar]
  6. Warren AL, de Watret KL, Wit, et al. The inflammatory response to cardiopulmonary bypass: part 2-Anti-inflammatory therapeutic strategies. J Cardiothor Vasc Anesth 2009;23(3):384–393. [CrossRef] [Google Scholar]
  7. Morariu AM, Loef BG, Aarts LPHJ, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting. Chest 2005;128(4):2677–2687. [CrossRef] [PubMed] [Google Scholar]
  8. Halonen J, Halonen P, Järvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery. JAMA 2007;297(14):1562–1567. [CrossRef] [PubMed] [Google Scholar]
  9. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 2008;29(21):2592–2600. [CrossRef] [PubMed] [Google Scholar]
  10. Whitlock RP, Young E, Noora J, Farrokhyar F, Blackall M, Teoh KH. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. J Surg Res 2006;132(2):188–194. [CrossRef] [PubMed] [Google Scholar]
  11. El Azab SR, Rosseel PMJ, de Lange JJ, et al. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002;88(4):496–501. [CrossRef] [PubMed] [Google Scholar]
  12. Kilger E, Weis F, Briegel J, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003;31(4):1068–1074. [CrossRef] [PubMed] [Google Scholar]
  13. Sano T, Morita S, Masuda M, Yasui H. Minor infection encouraged by steroid administration during cardiac surgery. Asian Cardiovasc Thorac Ann 2006;14(6):505–510. [CrossRef] [PubMed] [Google Scholar]
  14. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004;32(3):801–805. [CrossRef] [PubMed] [Google Scholar]
  15. Peng Z-Y, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008;36(5):1573–1577. [CrossRef] [PubMed] [Google Scholar]
  16. Schefold JC, von Haehling S, Corsepius M, et al. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin-6, and complement-activating product 5a. Shock 2007;28(4):418–425. [Google Scholar]
  17. Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS-A pragmatic approach for bedside intensivists summarizing the more recent advances. ASAIO J 2013;59(2):99–106. [CrossRef] [PubMed] [Google Scholar]
  18. Kellum JA. Hemoadsorption therapy for sepsis syndromes. Crit Care Med 2003;31(1):323–324. [CrossRef] [PubMed] [Google Scholar]
  19. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2006;81(1):137–143. [Google Scholar]
  20. Träger K, Fritzler D, Fischer G, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs 2016;39(3):141–146. [CrossRef] [PubMed] [Google Scholar]
  21. Träger K, Skrabal C, Fischer G, et al. Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass – a case series. Int J Artif Organs 2017;40(5):240–249. [CrossRef] [PubMed] [Google Scholar]
  22. Nemeth E, Kovacs E, Racz K, et al. Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study. Clin Transplant 2018;32(4):e13211. [CrossRef] [PubMed] [Google Scholar]
  23. Chen B, Feng M, Sheng C, Wanh Y, Cao W. The risk factors for delayed recovery in patients with cardiopulmonary bypass. Medicine 2021;100:11. [Google Scholar]
  24. Bove T, Calabro M, Londoni G, Aleti G, Marino G, Crescenzi G, Rosica C, Zangrilo A: The incidence and risk of acute renal failure in cardiac surgery. J Cardiothorac Vasc Anesth 2004;18(4):442–445. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.